Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Formulation
Sort By
Newest First
1 / 9
1 / 9
CRDO
Partnering with Scientific Excellence to De-Risk and Accelerate Drug Development
Silvia Steyrer-Gruber
Coriolis Pharma
PAO-07-24-CL-05
July 16, 2024
Liquid Suspensions
Beyond Pills: the Rise of Liquid Suspensions for Complex Formulations
Gus LaBella
Mikart
PAO-07-24-CL-04
July 09, 2024
Monoclonal Antibodies
Coriolis Pharma Launches U.S. Entity Alongside Innovative Drug Product Platform Service Offerings for Monoclonal Antibodies
Coriolis Pharma
PR-05-24-NI-02
June 18, 2024
Lipid Nanoparticles
Feasibility Studies and cGMP Design Supporting Continuous Lipid Nanoparticle Manufacturing
Jim Ziogas
DIANT Pharma
PAO-05-24-CL-03
May 30, 2024
mRNA Innovations
Technology Advances Needed to Drive Future mRNA Growth
Hagen Richter, Ph.D.
PAO-04-24-CL-04
April 15, 2024
mRNA–LNP Manufacturing
The Innovators Bringing Continuous Manufacturing to Lipid Nanoparticles
Antonio Costa, Ph.D.; William Pasek
DIANT Pharma
PAO-03-24-CL-08
March 18, 2024
Advanceability
Right from the Start: Designing Advanceable Formulations and Processes at Phase I
Serán Bioscience
PAO-02-24-CL-09
February 26, 2024
Biologics Formulation
Successful Formulation Development for Biologics Using a Unique Biophysical Prediction and Screening Platform
Pawel Stanczak, Ph.D.
Tanvex CDMO
PAO-02-24-CL-02
February 15, 2024
CDMO
Maximizing Outsourcing Benefits for Virtual Pharma Companies
William Kazimier
Tedor Pharma Services
PAO-09-23-CL-08
January 11, 2024
Lipid Nanoparticles
Facilitating Development and Scale-Up of Nanoparticle Drug Products with an End-to-End Adaptable Manufacturing Platform
Antonio Costa, Ph.D.
DIANT Pharma
PAO-10-23-CL-03
November 01, 2023
Failing Fast
Maximizing Resources and Potential for Success by Failing Fast
Nazar Elkarim, Ph.D.
Mikart
PAO-10-23-CL-02
October 23, 2023
Formulation
Addressing Swallowing and Palatability Issues with Patient-Friendly Dosage Forms
Gus LaBella
Mikart
PAO-09-23-CL-04
October 03, 2023
CDMO
Redesigning ANDA or Novel Drug Products at All Stages for the U.S. Market
Tedor Pharma Services
PAO-08-23-CL-06
September 26, 2023
Viscosity Reduction
Viscosity Reduction with An Excipient Platform and Feasibility Testing Service
Alana Gouveia
MilliporeSigma
PAO-08-23-CL-03
August 10, 2023
Alternative Excipient
Preparing Today for a Potential Ban on Titanium Dioxide in Pharmaceutical Drug Products
Almut von der Brelie
MilliporeSigma
PAO-08-23-CL-01
August 03, 2023
New Integrated mRNA Offering
Building on Experience and Investing in an Integrated mRNA Offering
Jessica Madigan; Normand Blais
BIOVECTRA
PAO-07-23-CL-03
July 31, 2023
Continuous Processing
US Food and Drug Administration (FDA) Purchase the LiFT System from DIANT® Pharma INC.
DIANT Pharma
PR-M07-23-03
July 31, 2023
Modified-Release Drug Formulations
Simplifying Modified-Release Drug Formulations with High-Quality Multiparticulate Cores
Donald Loveday, Ph.D.; Bill McCarthy; Doug Hovey
SPI Pharma
PAO-05-23-CL-06
June 06, 2023
Distribution
Redefining Innovation and Growth in Pharmaceutical Distribution
Ernest de Freitas
Univar Solutions
PAO-06-23-CL-03
June 06, 2023
Lipid Nanoparticles
Facilitating Lipid Nanoparticle Production with a Unique Continuous Manufacturing Solution
Antonio Costa, Ph.D.; William Pasek
DIANT Pharma
PAO-04-23-CL-05
May 06, 2023